AR126731A1 - Composiciones y métodos para tratar la mastitis - Google Patents

Composiciones y métodos para tratar la mastitis

Info

Publication number
AR126731A1
AR126731A1 ARP220102123A ARP220102123A AR126731A1 AR 126731 A1 AR126731 A1 AR 126731A1 AR P220102123 A ARP220102123 A AR P220102123A AR P220102123 A ARP220102123 A AR P220102123A AR 126731 A1 AR126731 A1 AR 126731A1
Authority
AR
Argentina
Prior art keywords
compositions
methods
treating mastitis
mastitis
treating
Prior art date
Application number
ARP220102123A
Other languages
English (en)
Inventor
Hilary Phelps
Brianna Joy Pomeroy Beam
Richard Andrew Ewin
Christopher A Zook
Michael Kuhn
Xi Zeng
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of AR126731A1 publication Critical patent/AR126731A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Reivindicación 1: Un método para tratar una mastitis en un sujeto, caracterizado porque comprende: administrar a dicho sujeto una cantidad eficaz de péptido catelicidina 2 (CATH2) o una variante de este, con lo cual se trata dicha mastitis en dicho sujeto.
ARP220102123A 2021-08-05 2022-08-05 Composiciones y métodos para tratar la mastitis AR126731A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202163229699P 2021-08-05 2021-08-05

Publications (1)

Publication Number Publication Date
AR126731A1 true AR126731A1 (es) 2023-11-08

Family

ID=85156347

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220102123A AR126731A1 (es) 2021-08-05 2022-08-05 Composiciones y métodos para tratar la mastitis

Country Status (2)

Country Link
AR (1) AR126731A1 (es)
WO (1) WO2023015274A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3150627T3 (en) * 2009-02-13 2019-03-11 Univ Utrecht Holding Bv ANTIMICROBIAL PEPTIDES BASED ON CMAP27
US20150284452A1 (en) * 2012-11-13 2015-10-08 Iogenetics, Llc Antimicrobial compositions
CA3207425A1 (en) * 2014-05-09 2015-11-12 Universiteit Utrecht Holding B.V. New cath2 derivatives
WO2020017980A1 (en) * 2018-07-20 2020-01-23 Quantec Limited Ingestible formulation

Also Published As

Publication number Publication date
WO2023015274A1 (en) 2023-02-09

Similar Documents

Publication Publication Date Title
CL2018003582A1 (es) Composiciones para modular la expresión de c9orf72 (divisional solicitud 201702567)
CY1126067T1 (el) Συντηγμενες πυρρολινες που δρουν σαν ειδικοι για ουβικιτινη αναστολεις πρωτεασης 30 (usp30)
MX2019001903A (es) Composiciones y metodos para modular la microflora gastrointestinal en un canino.
EA202190073A1 (ru) Композиции и способы лечения видов гемоглобинопатии и талассемии
MX2021001272A (es) Composiciones de bismuto-tiol y metodos de uso.
AR115585A1 (es) Composiciones y métodos para el tratamiento de la infiltración de grasa en músculo
EA202192925A1 (ru) Твердые формы ингибитора glyt1
PH12019500242A1 (en) 9-aminomethyl minocycline compounds and uses thereof
WO2018108991A3 (en) Methods of treating amyloid-beta peptide diseases
ZA202001568B (en) Methods and compositions for treating chronic lung diseases
MX2020009496A (es) Metodo para tratar asma o enfermedad alergica.
MX2018014966A (es) Peptidos monolipidados resistentes a proteasas.
AR124639A1 (es) Composición para el tratamiento de una enfermedad vascular, la prevención de una enfermedad vascular, el tratamiento de la hipertensión, o la prevención de la hipertensión
AR126731A1 (es) Composiciones y métodos para tratar la mastitis
DOP2021000215A (es) Tratamiento de la cefalea usando anticuerpo anti-cgrp
MY186286A (en) A pharmaceutical composition for improving or preventing progression of chronic kidney disease
EA201891337A3 (ru) Фармацевтическая композиция от нейропатической боли
AR122318A1 (es) Método para el tratamiento del cabello
MX2022002541A (es) Agente bioestimulante para tratar plantas y/o semillas de plantas.
AR103636A1 (es) Métodos de tratamiento de neuralgia postherpética con una formulación tópica de un compuesto de espiro-oxindol
EA202091446A1 (ru) Способы лечения хронических воспалительных заболеваний
EA202090535A1 (ru) Противомикробная композиция
WO2019126695A3 (en) Methods and pharmaceutical compositions for treating candida auris in blood
WO2017214394A3 (en) Methods of treating bone loss
MX2023002625A (es) Composiciones y metodos para proporcionar beneficios para la salud en un animal.